COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,223 Articles (22,733 medRxiv, 8,490 bioRxiv)

Most recent first Previous |  Page 1263: Articles 12621-12630  | Next

SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
van der Donk, L. E. H., Eder, J., van Hamme, J. L., Brouwer, P. J. M., Brinkkemper, M., van Nuenen, A. C., van Gils, M. J., Sanders, R. W., Kootstra, N. A., Bermejo-Jambrina, M., Geijtenbeek, T. B. H.
10.1101/2021.09.02.458667 — Posted: 2021-09-03
Characterization of SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy receptor
Ren, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Zhang, Y., Zhong, J., Zhong, G., Wang, X., Huang, A., Zhang, R., Ding, Q.
10.1101/2021.09.03.458829 — Posted: 2021-09-03
Strengthening public COVID-19 response with private facilities in Kisumu, Kenya
van Duijn, S., Barsosio, H. C., Omollo, M., Milimo, E., Odero, I. A., Aroka, R., de Sanctis, T., K Oloo, A., June, M. J., Houben, N., Wilming, C., Otieno, K., Kariuki, S., Onsongo, S., Odhiambo, A., Rinke de Wit, T.
10.1101/2021.08.31.21262891 — Posted: 2021-09-03
The impact of mental health and substance use issues on COVID-19 vaccine readiness: a cross sectional community-based survey in Ontario, Canada
Mehra, K., Markoulakis, R., Kodeeswaran, S., Redelmeier, D., Sinyor, M., MacKillop, J., Cheung, A., Levitt, E. E., Addison, T., Levitt, A. J.
10.1101/2021.08.30.21262844 — Posted: 2021-09-03
The COVID-19 pandemic and ophthalmic care: a qualitative study of patients with neovascular age-related macular degeneration (nAMD)
O'Connor, S. R., Treanor, C., Ward, E., Wickens, R. A., O'Connell, A., Culliford, L. A., Rogers, C. A., Gidman, E. A., Peto, T., Knox, P. C., Burton, B. J. L., Lotery, A. J., Sivaprasad, S., Reeves, B. C., Hogg, R. E., Donnelly, M., The MONARCH Study Group
10.1101/2021.09.01.21262696 — Posted: 2021-09-03
Tracking Covid-19 Cases and Deaths in the United States Distribution of Events by Day of Pandemic
Moore, A., Lyu, M., Hall, R.
10.1101/2021.08.30.21262851 — Posted: 2021-09-03
Wastewater-Based Epidemiology and Whole-Genome Sequencing for Community-Level Surveillance of SARS-CoV-2 in Selected Urban Communities of Davao City, Philippines: A Pilot Study
Otero, M. C. B., Murao, L. A. E., Limen, M. A. G., Gaite, P. L. A., Bacus, M. G., Acaso, J. T., Corazo, K., Knot, I. E., Sajonia, H., de los Reyes, F. L., Jaraula, C. M. B., Baja, E. S., Del Mundo, D. M. N.
10.1101/2021.08.27.21262450 — Posted: 2021-09-03
Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19
Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., Russell, C. D., Malinauskas, T., Millar, J., Elliott, K. S., Griffiths, F., Oosthuyzen, W., Morrice, K., Keating, S., Wang, B., Rhodes, D., Klaric, L., Zechner, M., Parkinson, N., Bretherick, A. D., Siddiq, A., Goddard, P., Donovan, S., Maslove, D., Nichol, A., Semple, M. G., Zainy, T., Maleady-Crowe, F., Todd, L., Salehi, S., Knight, J., Elgar, G., Chan, G., Arumugam, P., Fowler, T. A., Rendon, A., Shankar-Hari, M., Summers, C., Elliott, P., Yang, J., Wu, Y., GenOMICC Investigators, , 23andMe Investiga
10.1101/2021.09.02.21262965 — Posted: 2021-09-02
Structural and Biochemical Rationale for Enhanced Spike Protein Fitness in Delta and Kappa SARS-CoV-2 Variants
Saville, J. W., Mannar, D., Zhu, X., Srivastava, S. S., Berezuk, A. M., Demers, J.-P., Zhou, S., Tuttle, K., Sekirov, I., Kim, A., Li, W., Dimiter, D. S., Subramaniam, S.
10.1101/2021.09.02.458774 — Posted: 2021-09-02
Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
Liu, Y., Liu, J., Zou, J., Ren, P., Weaver, S., Xie, X., Shi, P.-Y.
10.1101/2021.09.02.458740 — Posted: 2021-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).